Acciones Aequus Pharmaceuticals Inc Toronto S.E.
Acciones
CA0076361033
Farmacéuticos
Ventas 2022 | 1,38 M 1,01 M 936 mil | Ventas 2023 | 255 mil 186 mil 173 mil | Capitalización | 3,32 M 2,42 M 2,25 M |
---|---|---|---|---|---|
Resultado Neto 2022 | -3 M -2,19 M -2,03 M | Resultado Neto 2023 | -2 M -1,46 M -1,36 M | VE / Ventas 2022 | 5,17 x |
Deuda neta 2022 | 2,49 M 1,81 M 1,69 M | Deuda neta 2023 | 4,89 M 3,57 M 3,32 M | VE / Ventas 2023 | 32,2 x |
P/E ratio 2022 |
-1,45
x | P/E ratio 2023 |
-1,12
x | Empleados | - |
Rendimiento 2022 * |
-
| Rendimiento 2023 |
-
| Flotante | 85,32 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Anne Stevens
FOU | Founder | - | 01/01/13 |
Douglas Janzen
CEO | Chief Executive Officer | 56 | 03/01/13 |
Ann Fehr
DFI | Director of Finance/CFO | 55 | 22/07/16 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Douglas Janzen
CEO | Chief Executive Officer | 56 | 03/01/13 |
Marc Lustig
BRD | Director/Board Member | 51 | 15/02/21 |
Director/Board Member | 54 | 18/12/14 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+52,42 % | 797 mil M | |
+40,35 % | 628 mil M | |
-7,21 % | 351 mil M | |
+16,69 % | 323 mil M | |
+11,39 % | 300 mil M | |
+16,98 % | 244 mil M | |
+1,23 % | 223 mil M | |
+5,08 % | 163 mil M | |
-5,61 % | 153 mil M |